754149-09-2 Usage
Uses
Used in Pharmaceutical Industry:
2H-Pyrano[3,2-b]pyridin-4-ol, 3,4-dihydro(9CI) is used as a potential active pharmaceutical ingredient for its antifungal and anti-inflammatory properties. It is being studied for its ability to combat fungal infections and reduce inflammation, which can be beneficial in treating various diseases and conditions.
Used in Organic Synthesis:
2H-Pyrano[3,2-b]pyridin-4-ol, 3,4-dihydro(9CI) is used as a building block in organic synthesis for the production of various pharmaceutical compounds. Its unique pyranopyridine ring structure allows for the development of new molecules with potential therapeutic applications.
However, it is important to note that further research is needed to fully understand the biological and chemical properties of 2H-Pyrano[3,2-b]pyridin-4-ol, 3,4-dihydro- (9CI), as well as to explore its potential applications in different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 754149-09-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,5,4,1,4 and 9 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 754149-09:
(8*7)+(7*5)+(6*4)+(5*1)+(4*4)+(3*9)+(2*0)+(1*9)=172
172 % 10 = 2
So 754149-09-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H9NO2/c10-6-3-5-11-7-2-1-4-9-8(6)7/h1-2,4,6,10H,3,5H2
754149-09-2Relevant academic research and scientific papers
FUNCTIONALLY SELECTIVE AZANITRILE ALPHA2C ADRENORECEPTOR AGONISTS
-
Page/Page column 76; 78, (2010/04/25)
In its many embodiments, the present invention provides a novel class of azanitrile compounds as inhibitors of α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, method
DERIVATIVES AND ANALOGS OF CHROMAN AS FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS
-
, (2008/12/08)
In its many embodiments, the present invention provides a novel class of chroman compounds of formula I as α2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of prepaxing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the α2C adrenergic receptors using such compounds or pharmaceutical compositions.
